001     866585
005     20220930130223.0
024 7 _ |a 10.2139/ssrn.3441425
|2 doi
024 7 _ |a 2128/24668
|2 Handle
037 _ _ |a FZJ-2019-05668
082 _ _ |a 540
100 1 _ |a Viegas, Aldino
|0 P:(DE-Juel1)161140
|b 0
245 _ _ |a Molecular Architecture of a Network of Potential Intracellular EGFR Modulators Involving the Juxtamembrane Segment, ARNO, Phospholipids and CaM
260 _ _ |a Cambridge, Mass.
|c 2020
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1586328892_20310
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Signaling of the Epidermal growth factor receptors (EGFRs) is a central cellular element and its dysregulation is related to a number of severe diseases. While ligand binding to the extracellular domain is the receptor’s most obvious regulatory element, also intracellular factors can act as modulators of EGFR activity. The juxtamembrane (JM) segment of the EGFR seems to be a key interaction interface of these cytoplasmic factors. However, very few JM-interacting molecules have been identified so far and even fewer is known about the molecular mechanism underlying JM-targeted receptor modulation. Here we report ARNO as a new EGFR-JM binding protein and provide high-resolution insights into its mode of interaction. We obtain comparable insights also for the known interaction partners Calmodulin and phospholipid bilayers containing different lipid compositions. Our results show clear similarities and distinct differences in each binding mode. Furthermore, we show that each interaction can be modulated by a set of additional orthogonal factors generating a distinctly regulated competitive network of possible EGFR modulators acting on the intracellular domain of the receptor. This newly identified interaction network and the obtained insights into the underlaying molecular mechanism may foster future EGFR-targeted therapeutic strategies.
536 _ _ |a 552 - Engineering Cell Function (POF3-552)
|0 G:(DE-HGF)POF3-552
|c POF3-552
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Yin, Dongsheng M.
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Borggräfe, Jan
|0 P:(DE-Juel1)168267
|b 2
700 1 _ |a Viennet, Thibault
|0 P:(DE-Juel1)161253
|b 3
700 1 _ |a Falke, Marcel
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Schmitz, Anton
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Famulok, Michael
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Etzkorn, Manuel
|0 P:(DE-Juel1)156341
|b 7
|e Corresponding author
773 _ _ |a 10.2139/ssrn.3441425
|0 PERI:(DE-600)2031189-8
|p 54-62
|t Structure
|v 28
|y 2020
|x 0969-2126
856 4 _ |u https://juser.fz-juelich.de/record/866585/files/19165CV0.pdf
856 4 _ |u https://juser.fz-juelich.de/record/866585/files/Autorenmanuskript%20Molecular%20Architecture%20of%20a%20Network%20of%20Potential%20Intracellular%20EGFR%20Modulators%20Involving%20the%20Juxtamembrane%20Segment%2C%20ARNO%2C%20Phospholipids%20and%20CaM%20Supplement.pdf
|y Restricted
856 4 _ |y OpenAccess
|z StatID:(DE-HGF)0510
|u https://juser.fz-juelich.de/record/866585/files/Autorenmanuskript%20Molecular%20Architecture%20of%20a%20Network%20of%20Potential%20Intracellular%20EGFR%20Modulators%20Involving%20the%20Juxtamembrane%20Segment%2C%20ARNO%2C%20Phospholipids%20and%20CaM.pdf
856 4 _ |x pdfa
|u https://juser.fz-juelich.de/record/866585/files/19165CV0.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:866585
|p openaire
|p open_access
|p OpenAPC
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)156341
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-552
|2 G:(DE-HGF)POF3-500
|v Engineering Cell Function
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2020
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
980 _ _ |a APC
980 1 _ |a APC
980 1 _ |a FullTexts
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21